ORBi: Detailled Reference

Article (Scientific journals)

Dopaminergic neurones: much more than dopamine?

Seutin, Vincent

2005 • In British Journal of Pharmacology, 146 (2), p. 167-9

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/2726

DOI
10.1038/sj.bjp.0706328

PubMed
16025140

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

SeutinBJP2005.pdf

Publisher postprint (96.94 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Dopamine/physiology; Dopamine Agents/pharmacology; Endocannabinoids/metabolism; Glutamic Acid/metabolism; Humans; Neurons/physiology

Abstract :

[en] Midbrain dopaminergic (DA) neurones sustain important physiological functions such as control of motricity, signalling of the error in prediction of rewards and modulation of emotions and cognition. Moreover, their degeneration leads to Parkinson's disease and they may be dysfunctional in other pathological states, such as schizophrenia and drug abuse. A subset of DA neurones has been known for many years to contain releasable peptides such as neurotensin and cholecystokinin. However, recent experimental evidence indicates that the phenotype of DA neurones may be much more diverse, since it is suggested that, under certain conditions, they may also release glutamate, cannabinoids and even serotonin.

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Seutin, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Pharmacologie

Language :

English

Title :

Dopaminergic neurones: much more than dopamine?

Publication date :

2005

Journal title :

British Journal of Pharmacology

ISSN :

0007-1188

Publisher :

Nature Publishing Group, London, United Kingdom

Volume :

146

Issue :

2

Pages :

167-9

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 16 April 2010

Statistics

Number of views

22 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

25

Scopus citations^®
without self-citations

25

OpenCitations

22

Bibliography

AGNATI, L. & FUXE, K. (2000). Volume transmission as a key feature of information handling in the central nervous system: possible new interpretative value of the Turing's B-type machine. Prog. Brain. Res., 125, 3-19.
BEAN, A.J. & ROTH, R.H. (1991). Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effect of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci., 11, 2694-2702.
BERGER, B., GASPAR, P. & VERNEY, C. (1992). Colocalization of neurotensin in the mesocortical dopaminergic system. Restricted regional and laminar distribution in rat, lack of colocalization in human. Ann. NY Acad. Sci., 668, 307-310.
BJORKLUND, A. & LINDVALL, O. (1984). Dopamine-containing Systems in the CNS. Amsterdam, New York, Oxford: Elsevier Science Publishers.
BOURQUE, M.J. & TRUDEAU, L.E. (2000). GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur. J. Neurosci., 12, 3172-3180.
BOYER, E.W. & SHANNON, M. (2005). The serotonin syndrome. N. Engl. J. Med., 353, 1112-1120.
CHUHMA, N., ZHANG, H., MASSON, J., ZHUANG, X., SULZER, D., HEN, R. & RAYPORT, S. (2004). Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J. Neurosci., 24, 972-981.
CORNIL, C.A., BALTHAZART, J., MOTTE, P., MASSOTTE, L. & SEUTIN, V. (2002). Dopamine activates noradrenergic receptors in the preoptic area. J. Neurosci., 22, 9320-9330.
DAHLSTRÖM, A. & FUXE, K. (1964). Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand., 62, 1-55.
DAL BO, G., ST-GELAIS, F., DANIK, M., WILLIAMS, S., COTTON, M. & TRUDEAU, L.E. (2004). Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J. Neurochem., 88, 1398-1405.
DESCARRIES, L., WATKINS, K.C., GARCIA, S., BOSLER, O. & DOUCET, G. (1996). Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol., 375, 167-186.
DIANA, M.A. & MARTY, A. (2004). Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol., 142, 9-19.
GRAS, C., HERZOG, E., BELLENCHI, G.C., BERNARD, V., RAVASSARD, P., POHL, M., GASNIER, B., GIROS, B. & EL MESTIKAWY, S. (2002). A third vesicular glutamate transporter expressed by cholinergic and serotonergic neurons. J. Neurosci., 22, 5442-5551.
HATTORI, T. (1993). Conceptual history of the nigrostriatal dopamine system. Neurosci. Res., 16, 239-262.
HOKFELT, T., REHFELD, J.F., SKIRBOLL, L., IVEMARK, B., GOLDSTEIN, M. & MARKEY, K. (1980). Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature, 285, 476-478.
JOHNSON, D.M. (1994). Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron, 12, 433-442.
LAVIN, A., NOGUERIA, L., LAPISH, C.C., WIGHTMAN, R.M., PHILLIPS, P.E. & SEAMANS, J.K. (2005). Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J. Neurosci., 25, 5013-5023.
MALENKA, R.C. & NICOLL, R.A. (1986). Dopamine decreases the calcium-activated after hyperpolarization in hippocampal CA1 pyramidal cells. Brain Res., 379, 210-215.
MELIS, M., PERRA, S., MUNTONI, A.L., PILLOLLA, G., LUTZ, B., MARSICANO, G., DI MARZO, V., GESSA, G.L. & PISTIS, M. (2004). Prefrontal cortex stimulation induces 2-arachidonoylglycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci., 24, 10707-10715.
MORON, J.A., BROCKINGTON, A., WISE, R.A., ROCHA, B.A. & HOPE, B.T. (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci., 22, 389-395.
PALACIOS, J.M., SAVASTA, M. & MENGOD, G. (1989). Does cholecystokinin colocalize with dopamine in the human substantia nigra? Brain Res., 488, 369-375.
RIEGEL, A. & LUPICA, C.R. (2004). Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci., 24, 11070-11078.
SAVASTA, M., PALACIOS, J.M. & MENGOD, G. (1990). Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. Mol. Brain Res., 7, 91-104.
SCHULTZ, W. & DICKINSON, A. (2000). Neuronal coding of prediction errors. Annu. Rev. Neurosci., 23, 473-500.
SEROOGY, K., CECCATELLI, S., SCHALLING, M., HOKFELT, T., FREY, P., WALSH, J., DOCKRAY, G., BROWN, J., BUCHAN, A. & GOLDSTEIN, M. (1988). A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin. Brain Res., 455, 88-98.
SHIGERI, Y., SEAL, R.P. & SHIMAMOTO, K. (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev., 45, 250-265.
STAMFORD, J.A., KRUK, Z.L. & MILLAR, J. (1990). Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res., 515, 171-180.
STORNETTA, R.L., SEVIGNY, C.P. & GUYENET, P.O. (2002). Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons. J. Comp. Neurol., 444, 191-206.
SUAREZ-ROCA, H. & CUBEDDU, L.X. (2002). The selective serotonin reuptake inhibitor citalopram induces the storage of serotinin in catecholaminergic terminals. J. Pharmacol. Exp. Ther., 302, 174-179.
SULZER, D., JOYCE, M.P., LIN, L., GELDWERT, D., HABER, S.N., HATTORI, T. & RAYPORT, S. (1998). Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci., 18, 4588-4602.
TRUDEAU, L.E. (2004). Glutamate co-transmission as an emerging concept in monoamine neuron function. Rev. Psychiatr. Neurosci., 29, 296-310.
ZHOU, F.M., LIANG, Y., SALAS, R., ZHANG, L., DE BIASI, M. & DANI, J.S. (2005). Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron, 46, 65-74.

Similar publications